October 01, 2025

How Safe Are FDA-Cleared AI Tools?

“These findings indicate that standardized efficacy, safety, and risk assessment reporting remains inadequate for FDA-cleared AI/ML devices, underscoring the need for dedicated regulatory pathways and robust postmarket surveillance to ensure patient safety."

Conexiant

September 30, 2025

Crisis Imaging: Mass Casualty Lessons Learned

Radiology department adaptations during unprecedented patient surge reveal preparedness strategies.

Conexiant

September 29, 2025

ACC Calls for Universal Inflammation Screening

New scientific statement positions hsCRP testing alongside cholesterol as evidence mounts for targeting residual inflammatory risk. 

Conexiant

September 29, 2025

Levodopa Investigated for Stroke Rehabilitation: ESTREL Trial

Swiss trial across 13 stroke units and 11 rehab centers challenges levodopa use in stroke recovery.

Conexiant

September 29, 2025

In-Flight Emergencies: 1 Per 212 Flights

Large global dataset quantifies in-flight emergencies; physician volunteers frequently involved and associated with diversion odds.

Conexiant

September 23, 2025

Juvenile SLE: Feasibility of Early Glucocorticoid Tapering

Early glucocorticoid tapering in juvenile systemic lupus erythematosus is feasible without added flare risk, though anti-double-stranded DNA positivity signals higher relapse odds.

Conexiant

September 22, 2025

Hospitalized TIA May Heighten Dementia and Stroke Risk

Patients with hospitalized TIA face higher long-term risks of cardiovascular disease and death.

Conexiant

September 18, 2025

Cuts or Care: ‘What Are the Priorities?’

New residency programs launch as Northern California faces ongoing physician shortages and potential funding reductions.

KFF Health News

September 18, 2025

Mount Sinai Secures $8M to Boost Drug Discovery for CADASIL and Brain Disorders

The transformational grant will launch a new center led by Dr. Fanny Elahi to pursue treatments for understudied neurovascular diseases

Mount Sinai New York